Skip to main content
. Author manuscript; available in PMC: 2015 Jul 7.
Published in final edited form as: Chembiochem. 2014 May 30;15(10):1508–1513. doi: 10.1002/cbic.201402077

Figure 1.

Figure 1

Glycosylated multicomponent vaccine reduces MT.MUC1 tumor burden in MUC1.Tg mice. MUC1.Tg mice were immunized with IFA as control, 1 and 2 in liposomes, or 3 and 4 together with IFA. Three biweekly immunizations were given prior to a tumor challenge with MUC1-expressing MT tumor cells (1 0 106 cells), followed by one boost one week after. The animals were sacrificed seven days after the last injection, and tumor wet weight was determined. Each data point represents an individual mouse, and the horizontal lines each indicate the mean for the group of mice. Asterisks indicate statistically significant differences (** P <0.01), and ns indicates no significant difference.